Calcific Coronary Arteriosclerosis, Coronary Artery Disease (CAD), Intravascular Lithotripsy; Rotational Atherectomy; OFDI, Intravascular Ultrasound, Optical Coherence Tomography (OCT), Orbital Atherectomy, Percutaneous Coronary Intervention
Conditions
Keywords
Coronary calcifications, coronary artery disease, percutaneous coronary intervention, intravascular imaging, atherectomy, intravascular lithotripsy, rotational atherectomy, orbital atherectomy, cutting balloon, target vessel failure
Brief summary
The OROBICA (Overviewing Real-World Outcomes to Boost Interventional Management of CAlcified Coronary Lesions) Registry is a multicenter, ambispective, real-world observational study designed to evaluate clinical, procedural, imaging, and economic outcomes of patients undergoing percutaneous coronary intervention (PCI) for severely calcified coronary artery disease. Coronary artery calcification represents one of the main determinants of procedural complexity and adverse outcomes in contemporary interventional cardiology. Despite the increasing availability of advanced calcium-modification technologies and intracoronary imaging techniques, evidence regarding the optimal treatment strategy in real-world clinical practice remains limited, particularly among high-risk and complex patients often underrepresented in randomized trials. The OROBICA Registry aims to systematically collect longitudinal data from all-comer patients treated for severely calcified coronary lesions using contemporary PCI strategies, including intracoronary imaging guidance (IVUS/OCT), rotational atherectomy, orbital atherectomy, intravascular lithotripsy, specialty balloons, and combined calcium-modification approaches. The primary objective is to assess clinical and procedural outcomes, with particular focus on target vessel failure (TVF). Secondary and exploratory objectives include evaluation of procedural success, imaging findings, predictors of adverse outcomes, healthcare resource utilization, and economic impact associated with the treatment of calcified coronary lesions. The registry is designed as a flexible research platform intended to support future hypothesis-generating analyses and provide real-world evidence to improve personalized management strategies for calcified coronary artery disease.
Interventions
PROCEDUREPercutaneous coronary intervention with or without stent implantation
In this registry patients will undergo PCI of severely calcified coronary arteries
Sponsors
Papa Giovanni XXIII Hospital
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients undergoing percutaneous coronary intervention (PCI) for severely calcified coronary lesions, angiographically defined as radiopacities noted without cardiac motion before contrast injection, generally involving both sides of the arterial wall. * Patients undergoing PCI for calcified coronary lesions with intracoronary optical coherence tomography (OCT) showing at least one of the following features: * calcium arc ≥180° * calcium thickness ≥0.3 mm * calcium length ≥3 mm * presence of calcified nodules * Patients undergoing PCI for calcified coronary lesions with intravascular ultrasound (IVUS) showing at least one of the following features: * calcium arc ≥180° * concentric or superficial calcium with extensive acoustic shadowing * presence of calcified nodules
Exclusion criteria
* Lack of availability of essential clinical or procedural data. * Refusal or withdrawal of informed consent for the prospective component of the registry, when applicable. * Exercise of the right to object to data processing, according to applicable data protection regulations.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of Target Vessel Failure (TVF) | 1, 2 and 5 years | Defined as composite of Cardiac Death, Target vessel Myocardial Infarction and Clinically-Driven Target Vessel Revascularization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of Major Adverse Cardiovascular Events (MACE) | 1, 2 and 5 years | Defined as composite of all-cause death, myocardial infarction (MI), stroke, clinically-driven target vessel revascularisation (CD-TVR) and hospitalization for cardiovascular causes |
Countries
Italy
Contacts
PRINCIPAL_INVESTIGATORFrancesco Moretti, MD
Papa Giovanni XXIII Hospital, Bergamo
Outcome results
None listed